Press Releases Releases |
|
Oct 5, 2004
HARRIS & HARRIS GROUP NOTES AWARD OF SUB-CONTRACT TO NANOSYS
|
42.5 KB
|
| |
Harris & Harris Group, Inc. noted today that Nanosys, Inc. signed an $8.2 million five year sub-contract awarded by Science Applications International Corporation (SAIC) to develop undisclosed sub-system components based on Nanosys' proprietary nanotechnology platform for use in systems for the U.S. Government. Under this contract, Nanosys will re...
|
Read more
|
|
Sep 30, 2004
ARTICLE ON CHLOROGEN IN BIOVENTURE VIEW
|
57.6 KB
|
| |
Shareholders may be interested in reading the article on page 15 of the September 10, 2004 publication Bioventure View entitled, "Chlorogen: the art of pharma-synthesis." The article discusses Chlorogen's chloroplast-based protein production technology and its commercialization strategy.
Privately held Chlorogen, Inc. is develop...
|
Read more
|
|
Sep 29, 2004
HARRIS & HARRIS GROUP INVESTS IN CRYSTAL IS, INC.
|
41.0 KB
|
| |
Harris & Harris Group, Inc. announced today that it has invested $200,000 as part of a $5 million Series A Preferred round of financing by privately held Crystal IS, Inc. The investor syndicate was led by Arch Venture Partners and included JVP, 3i and Harris & Harris Group.
Crystal IS is a supplier of ultra-low defect density native a...
|
Read more
|
|
Sep 8, 2004
HARRIS & HARRIS GROUP NOTES FDA APPROVAL OF CYMBALTA
|
41.9 KB
|
| |
Harris & Harris Group, Inc. noted today that the U.S. Food and Drug Administration (FDA) has approved Eli Lilly's Cymbalta (duloxetine HCI) for the management of pain associated with diabetic peripheral neuropathic pain (DNP). DNP is a symptom of nerve damage that affects up to five million Americans, Eli Lilly announced yesterday. Cymbalta is t...
|
Read more
|
|
Aug 19, 2004
HARRIS & HARRIS GROUP NOTES AWARD OF DARPA CONTRACT TO NANOSYS
|
43.0 KB
|
| |
Harris & Harris Group, Inc., noted today that the United States Defense Advanced Research Projects Agency (DARPA) awarded a contract to Nanosys, Inc., for up to approximately $14 million over a five-year period to develop nanotechnology-enabled solar cells for power generation solutions in military applications. The initial phase of development is...
|
Read more
|
|
Aug 16, 2004
HARRIS & HARRIS GROUP NOTES NEUROMETRIX SECOND QUARTER RESULTS
|
43.5 KB
|
| |
Harris & Harris Group, Inc., noted that NeuroMetrix, Inc. (NASDAQ: NURO), reported its financial results today for the second quarter ended June 30, 2004. Revenues were $4.3 million, up 106 percent from the second quarter of 2003. Gross profit margins were 72.8 percent, versus 69.5 percent in the corresponding quarter of 2003. To view NeuroMetri...
|
Read more
|
|
Aug 10, 2004
HARRIS & HARRIS GROUP INVESTS IN NANOOPTO CORPORATION
|
41.7 KB
|
| |
Harris & Harris Group, Inc., announced today that it has invested $887,500 as part of a $3.3 million round of financing by privately held NanoOpto Corporation (www.nanoopto.com). The funding is from existing equity partners Morgenthaler Ventures; U.S. Trust's Excelsior Venture Partners III, L.L.C.; Draper Fisher Jurvetson (DFJ) Gotham Ventures and...
|
Read more
|
|
Aug 9, 2004
ARTICLE IN BARRON's
|
56.7 KB
|
| |
Shareholders of Harris & Harris Group, Inc., may be interested in reading the story in today's Barron's, on page T3, entitled, "Investors Say "Nah" to Nanosys," by Eric J. Savitz.
Harris & Harris Group owns a 1.58 percent fully diluted interest in Nanosys, Inc., for which it paid $1.5 million in April 2003. On June 30, 2004, the ...
|
Read more
|
|
Aug 9, 2004
SANDRA A. MATRICK JOINS HARRIS & HARRIS GROUP AS GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
|
41.0 KB
|
| |
Harris & Harris Group, Inc., is pleased to announce that Sandra A. Matrick, J.D., has joined the firm as General Counsel, Chief Compliance Officer and Head of Human Resources. Ms. Matrick was previously an Associate in the Investment Management Group of Skadden, Arps, Slate, Meagher & Flom LLP. Ms. Matrick was graduated in the top five percent of...
|
Read more
|
|
Aug 6, 2004
ARTICLE IN FINANCIAL TIMES
|
48.9 KB
|
| |
Shareholders of Harris & Harris Group, Inc., may be interested in reading the story in today's Financial Times on page 21, entitled, "Nanosys Retreat Signals Rough Ride," by Richard Waters.
Harris & Harris Group owns a 1.58 percent fully diluted interest in Nanosys, Inc., for which it paid $1.5 million in April 2003. On June 30,...
|
Read more
|
|
Aug 4, 2004
HARRIS & HARRIS GROUP NOTES WITHDRAWL OF NANOSYS IPO
|
41.1 KB
|
| |
Harris & Harris Group, Inc., noted that Nanosys, Inc., has issued a press release today noting the withdrawal of its planned IPO owing to market conditions.
Harris & Harris Group owns a 1.58 percent fully diluted interest in Nanosys, Inc., for which it paid $1.5 million in April 2003. On June 30, 2004, the most recent date on which Harr...
|
Read more
|
|
Jul 30, 2004
ARTICLE ON MASS HIGH TECH.COM
|
40.3 KB
|
| |
Shareholders may be interested in reading the cover article on Mass High Tech (www.masshightech.com) entitled, "Nanotubes in space," by Matt Kelly. The article notes that Nantero, Inc. has formed a partnership with BAE Systems to explore how nanotubes might improve the performance of electronics in the aerospace and defense industries.
...
|
Read more
|
|
Jul 22, 2004
HARRIS & HARRIS GROUP NOTES NEUROMETRIX IPO
|
41.8 KB
|
| |
Harris & Harris Group, Inc., noted today that NEUROMetrix, Inc., has priced its initial public offering (IPO) of 3,000,000 shares of common stock at $8.00 per share. In 1996, Harris & Harris Group was the seed investor in NEUROMetrix, a spinout from the Harvard-M.I.T. Division of Health Science and Technology. Harris & Harris Group is the second ...
|
Read more
|
|
Jul 20, 2004
HARRIS & HARRIS GROUP REPORTS BALANCE SHEET AS OF JUNE 30, 2004
|
38.4 KB
|
| |
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 16 initial private equity investments have been in tiny-technology enabled companies. The Company has 17,248,845 ...
|
Read more
|
|
Jul 14, 2004
HARRIS & HARRIS GROUP INVESTS IN NANOGRAM CORPORATION
|
41.4 KB
|
| |
Harris & Harris Group, Inc., announced today that it has invested $950,000 as part of a $7 million follow-on secondary round of financing by privately held NanoGram Corporation (www.nanogram.com). Harris & Harris Group originally received shares of NanoGram Corporation as a spin off from NeoPhotonics Corporation, in which Harris & Harris Group is ...
|
Read more
|
|
Jul 14, 2004
HARRIS & HARRIS GROUP NOTES NANTERO AGREEMENT WITH BAE SYSTEMS
|
41.1 KB
|
| |
Harris & Harris Group, Inc., noted today that Nantero, Inc. (www.nantero.com), and BAE Systems (www.bae-systems.com) announced today a joint effort to evaluate the potential to develop carbon nanotube-based electronic devices for use in advanced defense and aerospace systems. The project will involve research and development of a variety of next-g...
|
Read more
|
|
Jul 7, 2004
HARRIS & HARRIS GROUP ANNOUNCES CLOSING OF FOLLOW-ON PUBLIC OFFERING AND FULL EXERCISE OF OVER-ALLOTMENT OPTION
|
49.1 KB
|
| |
New York, NY- Harris & Harris Group, Inc. (Nasdaq: TINY), today announced the closing of its follow-on offering. The Company also announced that the underwriters exercised their over-allotment option in full and will purchase an additional 450,000 shares of common stock at $11.25 per share. With the exercise of the over-allotment option, the Comp...
|
Read more
|
|
Jul 7, 2004
HARRIS & HARRIS GROUP NOTES NEUROMETRIX IPO ANNOUNCEMENT
|
43.0 KB
|
| |
NEUROMetrix, Inc., announced today a filing range of $10-$12 per share on its planned initial public offering of 3,000,000 common shares. The underwriters are Punk, Ziegel & Company and WR Hambrecht & Co. The Company has applied for a Nasdaq listing under the symbol: "NURO." Harris & Harris Group, Inc. owns 1,137,570 shares of NEUROMetrix and is...
|
Read more
|
|
Jun 30, 2004
HARRIS & HARRIS GROUP, INC. ANNOUNCES FOLLOW-ON PUBLIC OFFERING OF 3,000,000 SHARES OF COMMON STOCK AT $11.25 PER SHARE
|
51.6 KB
|
| |
Harris & Harris Group, Inc. (NASDAQ: TINY) today announced that it has priced a follow-on public offering of 3,000,000 shares of its common stock at a price of $11.25 per share for estimated net proceeds of approximately $31.7 million. The underwriters have a 30-day option to purchase up to 450,000 additional shares of its common stock from the co...
|
Read more
|
|
Jun 15, 2004
HARRIS & HARRIS GROUP FILES SUPPLEMENT TO SHELF REGISTRATION TO OFFER 2,500,000 SHARES OF COMMON STOCK
|
41.9 KB
|
| |
Harris & Harris Group, Inc. filed a supplementary prospectus to its shelf registration today, in which the Company proposes to offer 2,500,000 shares of its Common Stock through the underwriting firms, ThinkEquity Partners LLC, acting as lead managing underwriter, and Punk, Ziegel & Company, L.P. This communication is not an offering of any securi...
|
Read more
|
|
